IRadimed Statistics
Share Statistics
IRadimed has 12.72M
shares outstanding. The number of shares has increased by 0.4%
in one year.
| Shares Outstanding | 12.72M |
| Shares Change (YoY) | 0.4% |
| Shares Change (QoQ) | 0.33% |
| Owned by Institutions (%) | 54.83% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 41 |
| FTD / Avg. Volume | 0.12% |
Short Selling Information
The latest short interest is 196.6K, so 1.55% of the outstanding
shares have been sold short.
| Short Interest | 196.6K |
| Short % of Shares Out | 1.55% |
| Short % of Float | 2.45% |
| Short Ratio (days to cover) | 6.36 |
Valuation Ratios
The PE ratio is 36.23 and the forward
PE ratio is 25.86.
IRadimed's PEG ratio is
3.08.
| PE Ratio | 36.23 |
| Forward PE | 25.86 |
| PS Ratio | 9.51 |
| Forward PS | 8.5 |
| PB Ratio | 8.03 |
| P/FCF Ratio | 39.55 |
| PEG Ratio | 3.08 |
Financial Ratio HistoryEnterprise Valuation
IRadimed has an Enterprise Value (EV) of 644.78M.
| EV / Sales | 8.8 |
| EV / EBITDA | 28.3 |
| EV / EBIT | 25.16 |
| EV / FCF | 36.59 |
Financial Position
The company has a current ratio of 8.84,
with a Debt / Equity ratio of 0.
| Current Ratio | 8.84 |
| Quick Ratio | 7.62 |
| Debt / Equity | 0 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.01 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 22.15% and Return on Invested Capital is 19.34%.
| Return on Equity | 22.15% |
| Return on Assets | 19.56% |
| Return on Invested Capital | 19.34% |
| Revenue Per Employee | $457,763.26 |
| Profits Per Employee | $120,212.66 |
| Employee Count | 160 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 1.62 |
Taxes
| Income Tax | 5.04M |
| Effective Tax Rate | 20.77% |
Stock Price Statistics
The stock price has increased by 37.77% in the
last 52 weeks. The beta is 0.92, so IRadimed's
price volatility has been higher than the market average.
| Beta | 0.92 |
| 52-Week Price Change | 37.77% |
| 50-Day Moving Average | 52.44 |
| 200-Day Moving Average | 52.62 |
| Relative Strength Index (RSI) | 65.75 |
| Average Volume (20 Days) | 34,318 |
Income Statement
In the last 12 months, IRadimed had revenue of 73.24M
and earned 19.23M
in profits. Earnings per share was 1.52.
| Revenue | 73.24M |
| Gross Profit | 56.35M |
| Operating Income | 21.96M |
| Net Income | 19.23M |
| EBITDA | 22.78M |
| EBIT | 21.96M |
| Earnings Per Share (EPS) | 1.52 |
Full Income StatementBalance Sheet
The company has 52.23M in cash and 154.69K in
debt, giving a net cash position of 52.08M.
| Cash & Cash Equivalents | 52.23M |
| Total Debt | 154.69K |
| Net Cash | 52.08M |
| Retained Earnings | 56.79M |
| Total Assets | 101.73M |
| Working Capital | 66.66M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 25.62M
and capital expenditures -8.01M, giving a free cash flow of 17.62M.
| Operating Cash Flow | 25.62M |
| Capital Expenditures | -8.01M |
| Free Cash Flow | 17.62M |
| FCF Per Share | 1.39 |
Full Cash Flow StatementMargins
Gross margin is 76.94%, with operating and profit margins of 29.99% and 26.26%.
| Gross Margin | 76.94% |
| Operating Margin | 29.99% |
| Pretax Margin | 33.14% |
| Profit Margin | 26.26% |
| EBITDA Margin | 31.11% |
| EBIT Margin | 29.99% |
| FCF Margin | 24.06% |
